| Aug 9 |
Mind Medicine stock dips on proposed securities offering
|
| Aug 9 |
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
|
| Aug 7 |
MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA Therapy
|
| Aug 6 |
MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
|
| Aug 6 |
MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
|
| Jul 29 |
MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
|
| Jul 17 |
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
|
| Jun 28 |
Mind Medicine to join Russell 2000 index
|
| Jun 28 |
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
|
| Jun 26 |
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
|
